DARA Biosciences Stock Price, News & Analysis (NASDAQ:DARA)

$0.88 0.00 (0.00 %)
(As of 01/19/2018 03:13 PM ET)
Previous Close$0.88
Today's RangeN/A
52-Week Range$0.67 - $1.05
VolumeN/A
Average Volume118,843 shs
Market Capitalization$17.38 million
P/E Ratio-1.69
Dividend YieldN/A
Beta0.72

About DARA Biosciences (NASDAQ:DARA)

DARA Biosciences logoDARA BioSciences Inc is specialty pharmaceutical company based in the United States. The Company’s primary focus is on the commercialization of oncology treatment and oncology supportive care pharmaceutical products, including Soltamox, an oral solution of tamoxifen citrate; cancer support therapeutics, including Gelclair, indicated for the treatment of oral mucositis and Bionect, for the management of irritation of the skin as well as first and second degree burns, and Three Mission Pharmacal products, including Ferralet 90 (for anemia), Binosto (alendronate sodium effervescent tablet indicated for the treatment of osteoporosis) and Aquoral (for cancer related dry mouth). The Company has a clinical development asset, KRN5500, which is a Phase II product candidate targeted for treating cancer patients with painful treatment-refractory chronic chemotherapy induced peripheral neuropathy. The Company is a subsidiary of Midatech Pharma Plc.

Receive DARA News and Ratings via Email

Sign-up to receive the latest news and ratings for DARA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Specialty & Advanced Pharmaceuticals
Sub-IndustryN/A
SectorSpecialty & Advanced Pharmaceuticals
SymbolNASDAQ:DARA
CUSIPN/A
Phone+1-816-9147027

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-1.69230769230769
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS($0.52)
Net IncomeN/A
Net Margins-228.42%
Return on Equity-145.61%
Return on Assets-100.38%

Miscellaneous

EmployeesN/A
Outstanding Shares19,760,000

DARA Biosciences (NASDAQ:DARA) Frequently Asked Questions

What is DARA Biosciences' stock symbol?

DARA Biosciences trades on the NASDAQ under the ticker symbol "DARA."

How were DARA Biosciences' earnings last quarter?

DARA Biosciences Inc (NASDAQ:DARA) announced its quarterly earnings data on Monday, November, 2nd. The specialty pharmaceutical company reported ($0.14) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.14). The specialty pharmaceutical company earned $1.18 million during the quarter, compared to analysts' expectations of $0.83 million. DARA Biosciences had a negative return on equity of 145.61% and a negative net margin of 228.42%. View DARA Biosciences' Earnings History.

Who are some of DARA Biosciences' key competitors?

How do I buy DARA Biosciences stock?

Shares of DARA Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is DARA Biosciences' stock price today?

One share of DARA Biosciences stock can currently be purchased for approximately $0.88.

How big of a company is DARA Biosciences?

DARA Biosciences has a market capitalization of $17.38 million.

How can I contact DARA Biosciences?

DARA Biosciences' mailing address is 8601 Six Forks Rd Ste 160, RALEIGH, NC 27615-2965, United States. The specialty pharmaceutical company can be reached via phone at +1-816-9147027.


MarketBeat Community Rating for DARA Biosciences (DARA)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  52 (Vote Outperform)
Underperform Votes:  36 (Vote Underperform)
Total Votes:  88
MarketBeat's community ratings are surveys of what our community members think about DARA Biosciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

DARA Biosciences (NASDAQ:DARA) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

DARA Biosciences (NASDAQ:DARA) Earnings History and Estimates Chart

Earnings by Quarter for DARA Biosciences (NASDAQ:DARA)

DARA Biosciences (NASDAQ DARA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2015Q3 2015($0.14)($0.14)$0.83 million$1.18 millionViewN/AView Earnings Details
8/12/2015Q215($0.15)($0.14)$0.72 million$0.99 millionViewListenView Earnings Details
5/13/2015Q115($0.12)($0.16)$0.75 million$0.65 millionViewN/AView Earnings Details
3/3/2015Q4 2014($0.11)($0.04)$0.75 million$0.72 millionViewN/AView Earnings Details
11/5/2014Q3 2014($0.13)($0.11)$0.55 million$0.60 millionViewN/AView Earnings Details
8/12/2014Q114($0.18)($0.24)$0.30 million$0.41 millionViewN/AView Earnings Details
5/12/2014Q1 2014($0.35)($0.37)$0.22 million$0.16 millionViewN/AView Earnings Details
2/4/2014Q4 2013($0.45)($0.40)ViewN/AView Earnings Details
11/14/2013Q3 2013($0.50)($0.50)ViewN/AView Earnings Details
8/14/2013Q2 2013($0.50)($0.50)ViewN/AView Earnings Details
5/15/2013Q1 2013($0.50)($0.55)ViewN/AView Earnings Details
3/28/2013Q4 2012($0.50)($0.25)ViewN/AView Earnings Details
11/14/2012Q312($0.16)ViewN/AView Earnings Details
5/21/2012Q1 2012($0.95)($1.46)ViewN/AView Earnings Details
2/17/2012Q4 2011($2.27)ViewN/AView Earnings Details
11/14/2011Q3 2011($0.88)ViewN/AView Earnings Details
8/16/2011Q2 2011($1.40)($1.54)ViewN/AView Earnings Details
5/9/2011Q1 2011($1.32)ViewN/AView Earnings Details
11/14/2008Q3 2008($11.20)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

DARA Biosciences (NASDAQ:DARA) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for DARA Biosciences (NASDAQ:DARA)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

DARA Biosciences (NASDAQ DARA) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for DARA Biosciences (NASDAQ:DARA)

DARA Biosciences (NASDAQ DARA) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/3/2013Christopher G ClementPresidentBuy14,000$0.71$9,940.00View SEC Filing  
5/30/2013Haywood D CochraneDirectorBuy10,000$0.70$7,000.00View SEC Filing  
5/23/2013Timothy James HeadyDirectorBuy10,000$0.75$7,500.00View SEC Filing  
5/17/2013David DrutzCEOBuy25,000$0.70$17,500.00View SEC Filing  
9/17/2012David DrutzCEOBuy25,000$1.06$26,500.00View SEC Filing  
9/11/2012Haywood D CochraneDirectorBuy5,000$0.80$4,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

DARA Biosciences (NASDAQ DARA) News Headlines

Source:
DateHeadline
DARA Biosciences (DARA) & Its Peers Financial ReviewDARA Biosciences (DARA) & Its Peers Financial Review
www.americanbankingnews.com - December 4 at 7:39 PM
Head to Head Survey: Advanced Accelerator Application (AAAP) vs. DARA Biosciences (DARA)Head to Head Survey: Advanced Accelerator Application (AAAP) vs. DARA Biosciences (DARA)
www.americanbankingnews.com - December 3 at 8:14 AM
Head to Head Review: DARA Biosciences (DARA) vs. Its CompetitorsHead to Head Review: DARA Biosciences (DARA) vs. Its Competitors
www.americanbankingnews.com - December 2 at 1:30 AM
DARA Biosciences (DARA) versus The Competition Financial SurveyDARA Biosciences (DARA) versus The Competition Financial Survey
www.americanbankingnews.com - December 1 at 9:24 PM
Analyzing DARA Biosciences (DARA) & The CompetitionAnalyzing DARA Biosciences (DARA) & The Competition
www.americanbankingnews.com - November 30 at 7:26 PM
Reviewing DARA Biosciences (DARA) and Check-Cap (CHEK)Reviewing DARA Biosciences (DARA) and Check-Cap (CHEK)
www.americanbankingnews.com - November 30 at 5:28 PM
Contrasting DARA Biosciences (DARA) & The CompetitionContrasting DARA Biosciences (DARA) & The Competition
www.americanbankingnews.com - November 29 at 9:42 PM
DARA Biosciences (DARA) versus The Competition Critical SurveyDARA Biosciences (DARA) versus The Competition Critical Survey
www.americanbankingnews.com - November 27 at 11:26 AM
DARA Biosciences (DARA) versus Its Peers Critical ContrastDARA Biosciences (DARA) versus Its Peers Critical Contrast
www.americanbankingnews.com - November 26 at 1:30 PM
Financial Survey: AbbVie (ABBV) and DARA Biosciences (DARA)Financial Survey: AbbVie (ABBV) and DARA Biosciences (DARA)
www.americanbankingnews.com - November 20 at 5:46 PM
Financial Analysis: DARA Biosciences (DARA) and TherapeuticsMD (TXMD)Financial Analysis: DARA Biosciences (DARA) and TherapeuticsMD (TXMD)
www.americanbankingnews.com - November 19 at 11:34 AM
Head to Head Comparison: DARA Biosciences (DARA) vs. Its RivalsHead to Head Comparison: DARA Biosciences (DARA) vs. Its Rivals
www.americanbankingnews.com - November 15 at 1:38 PM
Head to Head Review: DARA Biosciences (DARA) and Its RivalsHead to Head Review: DARA Biosciences (DARA) and Its Rivals
www.americanbankingnews.com - November 14 at 5:18 AM
Aimmune Therapeutics (AIMT) and DARA Biosciences (DARA) Head-To-Head ReviewAimmune Therapeutics (AIMT) and DARA Biosciences (DARA) Head-To-Head Review
www.americanbankingnews.com - November 6 at 9:28 PM
Mallinckrodt PLC (MNK) versus DARA Biosciences (DARA) Head-To-Head ContrastMallinckrodt PLC (MNK) versus DARA Biosciences (DARA) Head-To-Head Contrast
www.americanbankingnews.com - November 5 at 5:54 PM
Analyzing DARA Biosciences (DARA) & Its RivalsAnalyzing DARA Biosciences (DARA) & Its Rivals
www.americanbankingnews.com - November 5 at 1:20 PM
KNOW Bio strengthens leadership with the addition of four new Board MembersKNOW Bio strengthens leadership with the addition of four new Board Members
www.bizjournals.com - October 24 at 8:10 PM
DARA Biosciences (DARA) vs. Assembly Biosciences (ASMB) Financial ReviewDARA Biosciences (DARA) vs. Assembly Biosciences (ASMB) Financial Review
www.americanbankingnews.com - October 4 at 2:36 PM
Comparing DARA Biosciences (DARA) and Supernus Pharmaceuticals (SUPN)Comparing DARA Biosciences (DARA) and Supernus Pharmaceuticals (SUPN)
www.americanbankingnews.com - September 16 at 4:24 AM
Analyzing Supernus Pharmaceuticals (SUPN) and DARA Biosciences (DARA)Analyzing Supernus Pharmaceuticals (SUPN) and DARA Biosciences (DARA)
www.americanbankingnews.com - September 1 at 4:16 AM
Scientists Take New Approach to Fighting Type 1 DiabetesScientists Take New Approach to Fighting Type 1 Diabetes
www.wsj.com - June 25 at 3:02 AM
Will microbes save agriculture? - Los Angeles TimesWill microbes save agriculture? - Los Angeles Times
www.latimes.com - May 28 at 4:06 PM
Will Midatech Pharma plc be the next Shire plc? - Motley Fool UKWill Midatech Pharma plc be the next Shire plc? - Motley Fool UK
www.fool.co.uk - May 4 at 4:08 PM
Midatech Loss Widens On Acquisition Costs, But Revenue Surges - London South East (registration) (blog)Midatech Loss Widens On Acquisition Costs, But Revenue Surges - London South East (registration) (blog)
www.lse.co.uk - April 13 at 4:14 PM
Midatech Loss Widens On Acquisition Costs, But Revenue SurgesMidatech Loss Widens On Acquisition Costs, But Revenue Surges
www.morningstar.co.uk - April 13 at 4:14 PM
MIDATECH PHARMA US INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of Delisting oMIDATECH PHARMA US INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of Delisting o
biz.yahoo.com - December 4 at 5:07 PM
DARA BIOSCIENCES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events, FinanciDARA BIOSCIENCES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events, Financi
biz.yahoo.com - December 2 at 4:32 PM
DARA BIOSCIENCES, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or StanDARA BIOSCIENCES, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stan
biz.yahoo.com - November 18 at 4:31 PM
DARA BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExDARA BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
biz.yahoo.com - November 2 at 4:36 PM

SEC Filings

DARA Biosciences (NASDAQ:DARA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

DARA Biosciences (NASDAQ:DARA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

DARA Biosciences (NASDAQ DARA) Stock Chart for Friday, January, 19, 2018

Loading chart…

This page was last updated on 1/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.